Mónica Pereira Garcia

Dr. Mónica Pereira Garcia

Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Guimarães, Braga, Portugal
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in Acta Biomaterialia
Verified
Journal Article
Closed access
AZAmir Zomorodian
Amir Zomorodian
MGMónica Pereira Garcia
Mónica Pereira Garcia
Teresa Moura E SilvaTeresa Moura E Silva
Teresa Moura E Silva
Joao FernandesJoao Fernandes
Joao Fernandes
MFMaria Helena V Fernandes
Maria Helena V Fernandes
Maria de Fatima MontemorMaria de Fatima Montemor
Maria de Fatima Montemor

24 September 2012 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
SRSandra C. Rodrigues
Sandra C. Rodrigues
CSChristiane Laranjo Salgado
Christiane Laranjo Salgado
ASAbhishek Sahu
Abhishek Sahu
MGMónica Pereira Garcia
Mónica Pereira Garcia
MFMaria Helena V Fernandes
Maria Helena V Fernandes
Fernando Jorge MonteiroFernando Jorge Monteiro
Fernando Jorge Monteiro

1 June 2015 in European Polymer Journal
Verified
Journal Article
Closed access
MRMarta Ribeiro
Marta Ribeiro
Mariana de MoraesMariana de Moraes
Mariana de Moraes
MBMarisa M. Beppu
Marisa M. Beppu
MGMónica Pereira Garcia
Mónica Pereira Garcia
MFMaria Helena V Fernandes
Maria Helena V Fernandes
Maria Pia FerrazMaria Pia Ferraz
Maria Pia Ferraz

19 July 2018 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
NSNadhia H. C. Souza
Nadhia H. C. Souza
RMRaquel Agnelli Mesquita-Ferrari
Raquel Agnelli Mesquita-Ferrari
MRMaria Fernanda Setúbal Destro Rodrigues
Maria Fernanda Setúbal Destro Rodrigues
DSDaniela Silva
Daniela Silva
BRBeatriz G. Ribeiro
Beatriz G. Ribeiro
KFKristianne Porta Santos Fernandes
Kristianne Porta Santos Fernandes
Macrophages play a very important role in the conduction of several regenerative processes mainly due to their plasticity and multiple functions. In the muscle repair process, while M1 macrophages regulate the inflammatory and proliferative phases, M2 (anti‐inflammatory) macrophages direct the differentiation and remodelling phases, leading to tissue regeneration. The aim of this study was to evaluate the effect of red and near infrared (NIR) photobiomodulation (PBM) on macrophage phenotypes and correlate these findings with the repair process following acute muscle injury. Wistar rats were divided into 4 groups: control; muscle injury; muscle injury + red PBM; and muscle injury + NIR PBM. After 2, 4 and 7 days, the tibialis anterior muscle was processed for analysis. Macrophages phenotypic profile was evaluated by immunohistochemistry and correlated with the different stages of the skeletal muscle repair by the qualitative and quantitative morphological analysis as well as by the evaluation of IL‐6, TNF‐α and TGF‐β mRNA expression. Photobiomodulation at both wavelengths was able to decrease the number of CD68+ (M1) macrophages 2 days after muscle injury and increase the number of CD163+ (M2) macrophages 7 days after injury. However, only NIR treatment was able to increase the number of CD206+ M2 macrophages (Day 2) and TGF‐β mRNA expression (Day 2, 4 and 7), favouring the repair process more expressivelly. Treatment with PBM was able to modulate the inflammation phase, optimize the transition from the inflammatory to the regeneration phase (mainly with NIR light) and improve the final step of regeneration, enhancing tissue repair.

31 December 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Margarida CostaMargarida Costa
Margarida Costa
MGMónica Pereira Garcia
Mónica Pereira Garcia
JCJoão Costa-Rodrigues
João Costa-Rodrigues
MCMaria Sofia Costa
Maria Sofia Costa
MRMaria João Ribeiro
Maria João Ribeiro
Rosário MartinsRosário Martins
Rosário Martins
The oceans remain a major source of natural compounds with potential in pharmacology. In particular, during the last few decades, marine cyanobacteria have been in focus as producers of interesting bioactive compounds, especially for the treatment of cancer. In this study, the anticancer potential of extracts from twenty eight marine cyanobacteria strains, belonging to the underexplored picoplanktonic genera, Cyanobium, Synechocystis and Synechococcus, and the filamentous genera, Nodosilinea, Leptolyngbya, Pseudanabaena and Romeria, were assessed in eight human tumor cell lines. First, a crude extract was obtained by dichloromethane:methanol extraction, and from it, three fractions were separated in a Si column chromatography. The crude extract and fractions were tested in eight human cancer cell lines for cell viability/toxicity, accessed with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and lactic dehydrogenase release (LDH) assays. Eight point nine percent of the strains revealed strong cytotoxicity; 17.8% showed moderate cytotoxicity, and 14.3% assays showed low toxicity. The results obtained revealed that the studied genera of marine cyanobacteria are a promising source of novel compounds with potential anticancer activity and highlight the interest in also exploring the smaller filamentous and picoplanktonic genera of cyanobacteria.